ATXS logo

Astria Therapeutics (ATXS) Depreciation And Amortization

Annual D&A

N/A

31 December 2023

All-time High

$395.00 K
ATXS annual depreciation & amortization is currently at an all-time high
Annual Total Expenses$67.83 M
ATXS annual total expenses is $67.83 million
Annual Operating Expenses$67.83 M
ATXS annual total operating expenses is $67.83 million
Annual Net Income-$72.89 M
ATXS annual net profit is -$72.89 million

ATXS Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

N/A

30 September 2024

All-time High

$105.00 K
ATXS quarterly depreciation & amortization is currently at an all-time high
Quarterly Total Expenses$29.01 M
ATXS quarterly total expenses is $29.01 million
Quarterly Operating Expenses$29.01 M
ATXS quarterly total operating expenses is $29.01 million
Quarterly Net Income-$24.53 M
ATXS quarterly net profit is -$24.53 million

ATXS Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

N/A

30 September 2024

All-time High

$395.00 K
ATXS TTM depreciation & amortization is currently at an all-time high
Annual Total Expenses$67.83 M
ATXS annual total expenses is $67.83 million
Annual Operating Expenses$67.83 M
ATXS annual total operating expenses is $67.83 million
TTM Net Income-$100.04 M
ATXS TTM net profit is -$100.04 million

ATXS TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ATXS Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

ATXS Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

Astria Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2018
$119.00 K(-60.9%)
$8000.00(+33.3%)
$119.00 K(-33.1%)
Sept 2018
-
$6000.00(-86.0%)
$178.00 K(-27.0%)
June 2018
-
$43.00 K(-30.6%)
$244.00 K(-12.2%)
Mar 2018
-
$62.00 K(-7.5%)
$278.00 K(-8.6%)
Dec 2017
$304.00 K(-23.0%)
$67.00 K(-6.9%)
$304.00 K(-8.4%)
Sept 2017
-
$72.00 K(-6.5%)
$332.00 K(-9.0%)
June 2017
-
$77.00 K(-12.5%)
$365.00 K(-6.6%)
Mar 2017
-
$88.00 K(-7.4%)
$391.00 K(-1.0%)
Dec 2016
$395.00 K
$95.00 K(-9.5%)
$395.00 K(+6.2%)
Sept 2016
-
$105.00 K(+1.9%)
$372.00 K(+22.4%)
DateAnnualQuarterlyTTM
June 2016
-
$103.00 K(+12.0%)
$304.00 K(+25.6%)
Mar 2016
-
$92.00 K(+27.8%)
$242.00 K(+19.8%)
Dec 2015
$202.00 K(-18.5%)
$72.00 K(+94.6%)
$202.00 K(+7.4%)
Sept 2015
-
$37.00 K(-9.8%)
$188.00 K(-10.9%)
June 2015
-
$41.00 K(-21.2%)
$211.00 K(-11.0%)
Mar 2015
-
$52.00 K(-10.3%)
$237.00 K(-4.4%)
Dec 2014
$248.00 K(-22.5%)
$58.00 K(-3.3%)
$248.00 K(+30.5%)
Sept 2014
-
$60.00 K(-10.4%)
$190.00 K(+46.2%)
June 2014
-
$67.00 K(+6.3%)
$130.00 K(+106.3%)
Mar 2014
-
$63.00 K
$63.00 K
Dec 2013
$320.00 K
-
-

FAQ

  • What is the all time high annual D&A for Astria Therapeutics?
  • What is the all time high quarterly D&A for Astria Therapeutics?
  • What is the all time high TTM D&A for Astria Therapeutics?

What is the all time high annual D&A for Astria Therapeutics?

Astria Therapeutics all-time high annual depreciation & amortization is $395.00 K

What is the all time high quarterly D&A for Astria Therapeutics?

Astria Therapeutics all-time high quarterly depreciation & amortization is $105.00 K

What is the all time high TTM D&A for Astria Therapeutics?

Astria Therapeutics all-time high TTM depreciation & amortization is $395.00 K